Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Madden

Showing results (271-280 of 855) with videos related to

Pageof 86
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 16, 1993
Effects of ethanol on the assay of acyl-CoA:cholesterol acyltransferase (ACAT)J L Smith, L J Madden, J de Jersey
International Journal of Group Psychotherapy|January 1, 1977
A group approach with violent outpatientsJ R Lion, R L Christopher, D J Madden
Expert Opinion on Drug Metabolism & Toxicology|July 16, 2015
Formulation and physiologic factors affecting the pharmacology of carrier-mediated anticancer agentsAndrew T Lucas, Andrew J Madden, William C Zamboni
Clinical Radiology|January 1, 1981
The role of radiotherapy in the treatment of soft tissue sarcoma: a retrospective study 1958--73M A Coe, F J Madden, R F Mould
Experimental and Clinical Psychopharmacology|June 5, 2018
Differential relations between delay discounting and distress tolerance as a function of opportunity cost and alcohol useJillian M Rung, Patrick S Johnson, Gregory J Madden
Federation Proceedings|March 27, 2010
The hydrolysis of acetylsalicylic acid by animal tissuesP K SMITH, H A HAND, R J MADDEN
Experimental and Clinical Psychopharmacology|October 7, 2009
Pathological gamblers discount probabilistic rewards less steeply than matched controlsGregory J Madden, Nancy M Petry, Patrick S Johnson
American Journal of Surgery|July 1, 1971
Effects of glucagon on the splanchnic and the systemic circulationJ J Madden, R M Ludewig, S L Wangensteen
American Journal of Surgery|October 1, 1971
Failure of glucagon in experimental hemorrhagic shockJ J Madden, R M Ludewig, S L Wangensteen
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|February 6, 2016
Challenges in preclinical to clinical translation for anticancer carrier-mediated agentsAndrew T Lucas, Andrew J Madden, William C Zamboni
Pageof 86

Showing results (271-280 of 855) with videos related to

Sort By:
Pageof 86
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 16, 1993
Effects of ethanol on the assay of acyl-CoA:cholesterol acyltransferase (ACAT)J L Smith, L J Madden, J de Jersey
International Journal of Group Psychotherapy|January 1, 1977
A group approach with violent outpatientsJ R Lion, R L Christopher, D J Madden
Expert Opinion on Drug Metabolism & Toxicology|July 16, 2015
Formulation and physiologic factors affecting the pharmacology of carrier-mediated anticancer agentsAndrew T Lucas, Andrew J Madden, William C Zamboni
Clinical Radiology|January 1, 1981
The role of radiotherapy in the treatment of soft tissue sarcoma: a retrospective study 1958--73M A Coe, F J Madden, R F Mould
Experimental and Clinical Psychopharmacology|June 5, 2018
Differential relations between delay discounting and distress tolerance as a function of opportunity cost and alcohol useJillian M Rung, Patrick S Johnson, Gregory J Madden
Federation Proceedings|March 27, 2010
The hydrolysis of acetylsalicylic acid by animal tissuesP K SMITH, H A HAND, R J MADDEN
Experimental and Clinical Psychopharmacology|October 7, 2009
Pathological gamblers discount probabilistic rewards less steeply than matched controlsGregory J Madden, Nancy M Petry, Patrick S Johnson
American Journal of Surgery|July 1, 1971
Effects of glucagon on the splanchnic and the systemic circulationJ J Madden, R M Ludewig, S L Wangensteen
American Journal of Surgery|October 1, 1971
Failure of glucagon in experimental hemorrhagic shockJ J Madden, R M Ludewig, S L Wangensteen
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|February 6, 2016
Challenges in preclinical to clinical translation for anticancer carrier-mediated agentsAndrew T Lucas, Andrew J Madden, William C Zamboni
Pageof 86